Precision BioSciences Inc (DTIL)

4.725 +0.22 (+5.00%) USD  |  NASDAQ  |  Dec 26, 16:00
4.96 +0.24 (+4.97%) Pre-Market: 20:00
More

Precision BioSciences Research and Development Expense (Quarterly): 13.08M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for DTIL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Pfizer Inc 2.598B
Assembly Biosciences Inc 13.52M
Protagonist Therapeutics Inc 35.97M
Alector Inc 48.00M
Entrada Therapeutics Inc 31.26M